Information PortalData Portal

Data Matrix

Tools & Workflows

Documentation

Tryptase alpha/beta-1 (Protein)

Description: A protein in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Tryptase alpha/beta-1 's neighborhood in the knowledge graph.

Knowledge Graph Assertions

	Source	Relation	Target	Evidence
Loading results...

DISPLAY PER PAGE

Report a bug

Data & Metadata

Tools & Use Cases

@CFDE Workbench 2024

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Data & Metadata

Tools & Use Cases

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2024

Knowledge Graph Assertions

	Source	Relation	Target	Evidence
	[4-(3-Aminomethyl-phenyl)-piperidin-1-yl]-(1-hexyl-1H-indol-3-yl)-methanone TFA Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Tryptase alpha/beta-1 Protein (Entity type)	Ki
	[4-(3-Aminomethyl-phenyl)-piperidin-1-yl]-(1-butyl-7-methyl-1H-indol-3-yl)-methanone TFA Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Tryptase alpha/beta-1 Protein (Entity type)	Ki
	1-Acetyl-2,5-dihydro-1H-pyrrole-2-carboxylic acid [1-(benzothiazole-2-carbonyl)-4-guanidino-butyl]-amide TFA Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Tryptase alpha/beta-1 Protein (Entity type)	Ki
	(S)-benzyl 6-amino-1-oxo-1-(5-((4-(3-phenylpropyl)piperazin-1-yl)methyl)-1,2,4-oxadiazol-3-yl)hexan-2-ylcarbamate Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Tryptase alpha/beta-1 Protein (Entity type)	Ki
	N-[(S)-5-amino-1-(5-{4-[2-(3-chloro-phenyl)-ethylcarbamoyl]-benzyl}-[1,2,4]oxadiazole-3-carbonyl)-pentyl]-3,5-difluoro-benzamide Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Tryptase alpha/beta-1 Protein (Entity type)	Ki
	(S)-benzyl 1-(5-(4-((3,4-dichlorophenethyl)carbamoyl)benzyl)-1,2,4-oxadiazol-3-yl)-6-amino-1-oxohexan-2-ylcarbamate Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Tryptase alpha/beta-1 Protein (Entity type)	Ki
	[4-(3-Aminomethyl-phenyl)-piperidin-1-yl]-(7-fluoro-1H-indol-3-yl)-methanone TFA Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Tryptase alpha/beta-1 Protein (Entity type)	Ki
	(S)-benzyl 1-(5-(4-(3-chlorophenethoxy)benzyl)-1,2,4-oxadiazol-3-yl)-6-amino-1-oxohexan-2-ylcarbamate Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Tryptase alpha/beta-1 Protein (Entity type)	Ki
	(S)-N-(1-(5-(4-(3,4-dichlorophenethoxy)benzyl)-1,2,4-oxadiazol-3-yl)-6-amino-1-oxohexan-2-yl)hexanamide hydrochloride Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Tryptase alpha/beta-1 Protein (Entity type)	Ki
	(S)-benzyl 1-(5-(3-phenethoxybenzyl)-1,2,4-oxadiazol-3-yl)-6-amino-1-oxohexan-2-ylcarbamate Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Tryptase alpha/beta-1 Protein (Entity type)	Ki

[4-(3-Aminomethyl-phenyl)-piperidin-1-yl]-(1-hexyl-1H-indol-3-yl)-methanone TFA
Compound (Entity type)
Bioactivity
Knowledge Graph Relation (Entity type)
Tryptase alpha/beta-1
Protein (Entity type)
Ki

[4-(3-Aminomethyl-phenyl)-piperidin-1-yl]-(1-butyl-7-methyl-1H-indol-3-yl)-methanone TFA
Compound (Entity type)
Bioactivity
Knowledge Graph Relation (Entity type)
Tryptase alpha/beta-1
Protein (Entity type)
Ki

1-Acetyl-2,5-dihydro-1H-pyrrole-2-carboxylic acid [1-(benzothiazole-2-carbonyl)-4-guanidino-butyl]-amide TFA
Compound (Entity type)
Bioactivity
Knowledge Graph Relation (Entity type)
Tryptase alpha/beta-1
Protein (Entity type)
Ki

(S)-benzyl 6-amino-1-oxo-1-(5-((4-(3-phenylpropyl)piperazin-1-yl)methyl)-1,2,4-oxadiazol-3-yl)hexan-2-ylcarbamate
Compound (Entity type)
Bioactivity
Knowledge Graph Relation (Entity type)
Tryptase alpha/beta-1
Protein (Entity type)
Ki

N-[(S)-5-amino-1-(5-{4-[2-(3-chloro-phenyl)-ethylcarbamoyl]-benzyl}-[1,2,4]oxadiazole-3-carbonyl)-pentyl]-3,5-difluoro-benzamide
Compound (Entity type)
Bioactivity
Knowledge Graph Relation (Entity type)
Tryptase alpha/beta-1
Protein (Entity type)
Ki

(S)-benzyl 1-(5-(4-((3,4-dichlorophenethyl)carbamoyl)benzyl)-1,2,4-oxadiazol-3-yl)-6-amino-1-oxohexan-2-ylcarbamate
Compound (Entity type)
Bioactivity
Knowledge Graph Relation (Entity type)
Tryptase alpha/beta-1
Protein (Entity type)
Ki

[4-(3-Aminomethyl-phenyl)-piperidin-1-yl]-(7-fluoro-1H-indol-3-yl)-methanone TFA
Compound (Entity type)
Bioactivity
Knowledge Graph Relation (Entity type)
Tryptase alpha/beta-1
Protein (Entity type)
Ki

(S)-benzyl 1-(5-(4-(3-chlorophenethoxy)benzyl)-1,2,4-oxadiazol-3-yl)-6-amino-1-oxohexan-2-ylcarbamate
Compound (Entity type)
Bioactivity
Knowledge Graph Relation (Entity type)
Tryptase alpha/beta-1
Protein (Entity type)
Ki

(S)-N-(1-(5-(4-(3,4-dichlorophenethoxy)benzyl)-1,2,4-oxadiazol-3-yl)-6-amino-1-oxohexan-2-yl)hexanamide hydrochloride
Compound (Entity type)
Bioactivity
Knowledge Graph Relation (Entity type)
Tryptase alpha/beta-1
Protein (Entity type)
Ki

(S)-benzyl 1-(5-(3-phenethoxybenzyl)-1,2,4-oxadiazol-3-yl)-6-amino-1-oxohexan-2-ylcarbamate
Compound (Entity type)
Bioactivity
Knowledge Graph Relation (Entity type)
Tryptase alpha/beta-1
Protein (Entity type)
Ki

DISPLAY PER PAGE